Treatment
of cis-(dfmp)2PtMe2 (dfmp =
(C2F5)2PMe) with the mesitylenium
acid (C6Me3H4)+B(C6F5)4
– in 1,2-difluorobenzene
cleanly produces an unusually stable arene complex, [(η6-C6Me3H3)Pt(dfmp)(CH3)]+(B(C6F5)4)− (1). Facile arene exchange and competitive
binding equilibria have been quantified for mesitylene relative to
toluene (K = 0.0030(3)) and durene (K = 20(2)). Reaction of 1 with H2 at 80 °C
results in hydrogenolysis to form the arene hydride (η6-C6Me3H3)Pt(dfmp)(H)+ (2), while treatment of 1 with CO gives trans-(dfmp)2Pt(CO)Me+ as the major
phosphine product. Addition of excess Me3P to 1 results in both arene and dfmp displacement to form (Me3P)3PtMe+. (η6-C6Me3H3)Pt(dfmp)(CH3)+ is
a moderately active ethylene dimerization catalyst to form 2-butenes
(∼7 TO h–1, 20 °C).
The synthesis and structural characterization of 2-and 3-coordinate Pt(0) complexes with -acceptor perfluoroalkylphosphine ligands (PFAP's) is reported. (dfebp) 2 Pt (dfebp = (C 2 F 5) 2 P t Bu) was prepared in moderate yield by either thermolysis of (cod)Pt(Ph) 2 in neat dfebp or, more efficiently, by the treatment of (nbe) 3 Pt with 2 equiv. dfebp in the presence of H 2. Addition of 1 equiv. CF 3 CO 2 H to (dfebp) 2 Pt generates the expected Pt(II) trans-(dfebp) 2 Pt(O 2 CCF 3)(H) product, while treatment with the mesitylenium acid (C 6 Me 3 H 4) + B(C 6 F 5) 4 leads to phosphine loss and formation of the arene complex [( 6-C 6 Me 3 H 3)Pt(dfmp)(CH 3)] + (B(C 6 F 5) 4)-. Addition of ethylene to (dfebp) 2 Pt results in facile and reversible equilibria with the ethylene adducts (dfebp) 2 Pt(C 2 H 4) and (dfebp)Pt(C 2 H 4) 2 , which have been quantified by VT NMR spectroscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.